Literatura académica sobre el tema "Drug Delivery engineering"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Drug Delivery engineering".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Drug Delivery engineering"
Costa, Pedro F. "Bone Tissue Engineering Drug Delivery". Current Molecular Biology Reports 1, n.º 2 (11 de abril de 2015): 87–93. http://dx.doi.org/10.1007/s40610-015-0016-0.
Texto completoYang, Xiaosong, Shizhu Chen, Xiao Liu, Miao Yu y Xiaoguang Liu. "Drug Delivery Based on Nanotechnology for Target Bone Disease". Current Drug Delivery 16, n.º 9 (4 de diciembre de 2019): 782–92. http://dx.doi.org/10.2174/1567201816666190917123948.
Texto completoLiang, Yujie, Li Duan, Jianping Lu y Jiang Xia. "Engineering exosomes for targeted drug delivery". Theranostics 11, n.º 7 (2021): 3183–95. http://dx.doi.org/10.7150/thno.52570.
Texto completoSarker, Dipak. "Engineering of Nanoemulsions for Drug Delivery". Current Drug Delivery 2, n.º 4 (1 de octubre de 2005): 297–310. http://dx.doi.org/10.2174/156720105774370267.
Texto completoLiang, Yujie, Li Duan, Jianping Lu y Jiang Xia. "Engineering exosomes for targeted drug delivery". Theranostics 11, n.º 7 (2021): 3183–95. http://dx.doi.org/10.7150/thno.52570.
Texto completoTiwari, Ashutosh. "Drug Delivery & Tissue Engineering Conference". Advanced Materials Letters 8, n.º 9 (1 de septiembre de 2017): 883. http://dx.doi.org/10.5185/amlett.2017/9001.
Texto completoHu, Quanyin, Hunter N. Bomba y Zhen Gu. "Engineering platelet-mimicking drug delivery vehicles". Frontiers of Chemical Science and Engineering 11, n.º 4 (15 de febrero de 2017): 624–32. http://dx.doi.org/10.1007/s11705-017-1614-6.
Texto completoLadewig, Katharina. "Drug delivery in soft tissue engineering". Expert Opinion on Drug Delivery 8, n.º 9 (16 de junio de 2011): 1175–88. http://dx.doi.org/10.1517/17425247.2011.588698.
Texto completoRaemdonck, Koen, Joseph Demeester y Stefaan De Smedt. "Advanced nanogel engineering for drug delivery". Soft Matter 5, n.º 4 (2009): 707–15. http://dx.doi.org/10.1039/b811923f.
Texto completoHacisalihzade, S. S. "Control engineering and therapeutic drug delivery". IEEE Control Systems Magazine 9, n.º 4 (junio de 1989): 44–45. http://dx.doi.org/10.1109/37.24840.
Texto completoTesis sobre el tema "Drug Delivery engineering"
Albed, Alhnan Mohamed. "Engineering polymethacrylic microparticles for oral drug delivery". Thesis, University of London, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.543262.
Texto completoWendel, Sebastian Oliver. "Bacteria as drug delivery vehicles". Diss., Kansas State University, 2014. http://hdl.handle.net/2097/18804.
Texto completoDepartment of Chemical Engineering
Stefan H. Bossmann
Both chemotherapy for cancer treatment and antibiotic therapy for bacterial infections require systemic applications of the drug and a systemic application is always linked to a number of disadvantages. To circumvent these a targeted drug delivery system was developed. It utilizes the ability of phagocytes from the hosts own immune system to recognize and internalize antigens. Deactivated M. luteus, a non-pathogenic gram positive bacteria was loaded with high concentrations (exceeding the IC50 at least 60 fold in local intracellular concentration) the chemotherapeutics doxorubicin or DP44mt or with the bactericidal chlorhexidine. The modified bacteria is fed to phagocytes (Monocytes/Macrophages or neutrophils) and serves as protective shell for the transporting and targeting phagocyte. The phagocyte is recruited to the tumor site or site of infection and releases the drug along with the processed M. luteus via the exosome pathway upon arrival. The chlorhexidine drug delivery system was successfully tested both in vitro and in vivo, reducing the pathogen count and preventing systemic spread of a F. necrophorum infection in a mouse model. The doxorubicin drug delivery system reduced the viability of 4T1 cancer cells to 20% over the course of four days in vitro.
Bansode, Ratnadeep V. "Functional ionic liquids in crystal engineering and drug delivery". Thesis, University of Bradford, 2016. http://hdl.handle.net/10454/14563.
Texto completoSocial Justice Department, Government of Maharashtra, India.
Bansode, Ratnadeep Vitthal. "Functional ionic liquids in crystal engineering and drug delivery". Thesis, University of Bradford, 2016. http://hdl.handle.net/10454/14563.
Texto completoLee, Heejin 1976. "Drug delivery device for bladder disorders". Thesis, Massachusetts Institute of Technology, 2009. http://hdl.handle.net/1721.1/58169.
Texto completoCataloged from PDF version of thesis.
Includes bibliographical references (p. 100-104).
Several pathologies associated with the bladder have wide impacts on society. Overactive bladder (OAB) and interstitial cystitis/painful bladder syndrome (IC/PBS) are chronic urological conditions characterized by pain, urinary frequency, and urgency with or without urinary incontinence. The estimated prevalence of OAB and IC/PBS is more than 34 million people in the U.S. alone. The American Cancer Society estimated a total of 68,810 new bladder cancer cases and 14,100 deaths from bladder cancer in the U.S. in 2008. Treatment options include oral medications, transdermal patches and intravesical instillations of therapeutic solutions. Direct intravesical instillation is considered an effective option, especially for those who remain refractory to oral and transdermal formulations due to intolerable side effects and skin irritations, respectively. Intravesical treatment, however, requires repeated instillations due to rapid drug voiding by urination, and the frequent urinary catheterizations involve risk of urinary infection and patient discomfort. An alternative, site-specific local delivery approach was created using a reservoir-based drug delivery device. This novel passive device was designed to release drug in a predetermined manner once inside the bladder. The device also possesses a retention feature to prevent accidental voiding. The device can be implanted into and retrieved from the bladder by a non-surgical cystoscopic procedure.
(cont.) In vivo tests using lidocaine, a local anesthetic used for IC/PBS treatment, showed that a sustained and local treatment to the bladder can be achieved with the device. The lidocaine bladder tissue concentration was found to be a thousand-fold higher than the lidocaine plasma concentration at three and six days in a rabbit model. The device approach has the potential to achieve localized therapy to the bladder while minimizing side effects. Future studies may use the device for other therapeutic agents in the treatment of OAB, IC/PBS, and bladder cancer.
by Heejin Lee.
Ph.D.
Dellal, David (David M. ). "Microneedle gastric retention for drug delivery". Thesis, Massachusetts Institute of Technology, 2017. http://hdl.handle.net/1721.1/118020.
Texto completoCataloged from PDF version of thesis.
Includes bibliographical references (pages 25-28).
Traditional drug delivery methods, such as injection and ingestion, are associated with many challenges, including patient needle-phobia and patient adherence to a medication regimen. Biologic molecules, in particular, must be injected due to degradation by enzymes in the GI tract. Previous scientists have developed a method with the potential to inject macromolecules in the GI tract using microneedles that can implant themselves in the stomach lining; however, they do not provide long-term drug delivery. To create a controlled release micro injection, I hypothesize that a hooked needle will latch onto the muscularis mucosae layer in the stomach and reside.upwards of a week to deliver drugs. A number of trials and simulations have been designed to test the efficacy of this retention mechanism. Coupled with work in the creation of new pharmaceutical formulations, these needles can be loaded with any drug to ensure uptake into the blood stream over the course of several days.
by David Dellal.
S.B.
Chauhan, Vikash Pal Singh. "Re-Engineering the Tumor Microenvironment to Enhance Drug Delivery". Thesis, Harvard University, 2012. http://dissertations.umi.com/gsas.harvard:10405.
Texto completoEngineering and Applied Sciences
Lei, Wang S. "Fabrication of drug delivery MEMS devices". Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/58271.
Texto completo"May 2007." Cataloged from PDF version of thesis.
Includes bibliographical references (p. 19).
There is considerable amount of interest in the immediate treatment of personnel involved in high risk situations on the battlefield. A novel approach to drug delivery on the battlefield based on MEMS technology is discussed. By combining three separately fabricated layers, a single implantable drug delivery device capable of delivering up to 100 mm3 of a vasopressin solution was developed. In vitro release of vasopressin was observed and the I-V response of the bubble generator was characterized. Results show that the voltage at the time of release is ~11V while the current is ~0.35A, giving a power output of 3.79W. The time to total release of the drug was less than 2 minutes.
by Wang Lei.
S.B.
Dyer, Robert J. (Robert Joseph) 1977. "Needle-less injection system for drug delivery". Thesis, Massachusetts Institute of Technology, 2003. http://hdl.handle.net/1721.1/89388.
Texto completoForbes, Zachary Graham Barbee Kenneth A. "Magnetizable implants for targeted drug delivery /". Philadelphia, Pa. : Drexel University, 2005. http://dspace.library.drexel.edu/handle/1860/472.
Texto completoLibros sobre el tema "Drug Delivery engineering"
Drug delivery: Engineering principles for drug delivery. New York: Oxford University Press, 2001.
Buscar texto completoNanotechnology and drug delivery. Boca Raton: Taylor & Francis, 2014.
Buscar texto completoBader, Rebecca A. y David A. Putnam, eds. Engineering Polymer Systems for Improved Drug Delivery. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118747896.
Texto completoLamprou, Dimitrios. Emerging Drug Delivery and Biomedical Engineering Technologies. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003224464.
Texto completoSurya, Mallapragada, ed. Biomaterials for drug delivery and tissue engineering. Warrendale, Pa: Materials Research Society, 2001.
Buscar texto completoDan, Luo y Saltzman W. Mark, eds. Synthetic DNA delivery systems. Georgetown, Tex: Landes Bioscience, 2003.
Buscar texto completoTiwari, Ashutosh y Atul Tiwari, eds. Nanomaterials in Drug Delivery, Imaging, and Tissue Engineering. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118644591.
Texto completoGregoriadis, Gregory. Engineering liposomes for drug delivery: Progress and problems. New York: Elsevier, 1995.
Buscar texto completoAtul, Tiwari, ed. Nanomaterials in drug delivery, imaging, and tissue engineering. Hoboken, New Jersey: John Wiley & Sons, 2013.
Buscar texto completoNanomedicine and drug delivery. Toronto: Apple Academic Press, 2013.
Buscar texto completoCapítulos de libros sobre el tema "Drug Delivery engineering"
Shoyele, Sunday A. "Engineering Protein Particles for Pulmonary Drug Delivery". En Drug Delivery Systems, 149–60. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-210-6_7.
Texto completoRossi, Filippo, Giuseppe Perale y Maurizio Masi. "Introduction: Chemical Engineering and Medicine". En Controlled Drug Delivery Systems, 1–7. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-02288-8_1.
Texto completoKaialy, Waseem y Ali Nokhodchi. "Particle Engineering for Improved Pulmonary Drug Delivery Through Dry Powder Inhalers". En Pulmonary Drug Delivery, 171–98. Chichester, UK: John Wiley & Sons, Ltd, 2015. http://dx.doi.org/10.1002/9781118799536.ch8.
Texto completoDrinnan, Charles T., Laura R. Geuss, Ge Zhang y Laura J. Suggs. "Tissue Engineering in Drug Delivery". En Fundamentals and Applications of Controlled Release Drug Delivery, 533–68. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-0881-9_17.
Texto completoEl-Gendy, Nashwa, Mark M. Bailey y Cory Berkland. "Particle Engineering Technologies for Pulmonary Drug Delivery". En Controlled Pulmonary Drug Delivery, 283–312. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-9745-6_13.
Texto completoBader, Rebecca A. "Fundamentals of Drug Delivery". En Engineering Polymer Systems for Improved Drug Delivery, 1–28. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118747896.ch1.
Texto completoMuppalaneni, Srinath, David Mastropietro y Hossein Omidian. "Mucoadhesive Drug Delivery Systems". En Engineering Polymer Systems for Improved Drug Delivery, 319–42. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118747896.ch10.
Texto completoFu, Andrew S. y Horst A. von Recum. "Affinity-Based Drug Delivery". En Engineering Polymer Systems for Improved Drug Delivery, 429–52. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118747896.ch13.
Texto completoWardwell, Patricia R. y Rebecca A. Bader. "Challenges of Drug Delivery". En Engineering Polymer Systems for Improved Drug Delivery, 29–54. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118747896.ch2.
Texto completoSolorio, Luis, Angela Carlson, Haoyan Zhou y Agata A. Exner. "Implantable Drug Delivery Systems". En Engineering Polymer Systems for Improved Drug Delivery, 189–225. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118747896.ch7.
Texto completoActas de conferencias sobre el tema "Drug Delivery engineering"
Shum, Ho Cheung, Tiantian Kong, Zhou Liu y Yang Song. "Engineering Drug Delivery Vehicles With Multiphase Microfluidics". En ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/nemb2013-93028.
Texto completoBlanco, Letia, Panos S. Shiakolas, Pranesh B. Aswath, Christopher B. Alberts, Chris Grace, Kyle Godfrey y Drew Patin. "A Thermoresponsive Hydrogel Based Controlled Drug Delivery Device". En ASME 2012 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/imece2012-88564.
Texto completoPang, G. K. H. y DaPeng Qiao. "Iontophoretic drug delivery models". En 2011 1st Middle East Conference on Biomedical Engineering (MECBME). IEEE, 2011. http://dx.doi.org/10.1109/mecbme.2011.5752133.
Texto completoMaloney, John M. "An Implantable Microfabricated Drug Delivery System". En ASME 2003 International Mechanical Engineering Congress and Exposition. ASMEDC, 2003. http://dx.doi.org/10.1115/imece2003-43186.
Texto completoShafahi, Maryam y Parham Piroozan. "Model of Drug Delivery to the Eye". En ASME 2014 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/imece2014-39438.
Texto completoRong Tong, Li Tang, Qian Yin y Jianjun Cheng. "Drug-polyester conjugated nanoparticles for cancer drug delivery". En 2011 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2011. http://dx.doi.org/10.1109/iembs.2011.6092056.
Texto completoKim, Jinho y Jim S. Chen. "Effect of Inhaling Patterns on Aerosol Drug Delivery: CFD Simulation". En ASME 2008 International Mechanical Engineering Congress and Exposition. ASMEDC, 2008. http://dx.doi.org/10.1115/imece2008-66685.
Texto completoClima, L., A. Rotara, C. Cojocaru, M. Pinteala y B. C. Simionescu. "Polymer engineering focusing on DRUG/GENE delivery and tissue engineering". En 2015 E-Health and Bioengineering Conference (EHB). IEEE, 2015. http://dx.doi.org/10.1109/ehb.2015.7391491.
Texto completoLuo, Yangyang y David K. Mills. "Chitosan-Halloysite Hydrogel Drug Delivery System". En 2016 32nd Southern Biomedical Engineering Conference (SBEC). IEEE, 2016. http://dx.doi.org/10.1109/sbec.2016.55.
Texto completoBellazzi, R. "Predictive fuzzy controllers for drug delivery". En Second International Conference on `Intelligent Systems Engineering'. IEE, 1994. http://dx.doi.org/10.1049/cp:19940635.
Texto completo